Alteco Medical offers a medical device for extracorporeal blood purification. The product removes endotoxin (lipopolysaccharide, LPS) from the patient’s bloodstream, and is applied as an add-on therapy in sepsis to treat endotoxemia (high levels of endotoxin). This can help stabilize the patient in acute situations. Endotoxemia is often present in sepsis, a life-threatening condition and one of the most common causes of death in modern intensive care.

Quotes for Alteco Medical AB

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Anders Althin (tf)

Chairperson of the Board

  • Mats Wahlström

Board

  • Anders Althin
  • Charlotte Althin Hicks
  • Articles of association

    • News

    Show More

    Analysis

    Largest Owners

    Name Capital % Votes % Date
    Anders Althin 90,09 90,09 2025-01-27
    Avanza Pension 0,49 0,49 2024-12-23
    Nordnet Pensionsförsäkring 0,36 0,36 2024-12-23
    Ingvar Andersson 0,31 0,31 2024-12-23
    Magnus Lundberg 0,28 0,28 2024-12-23
    Handelsbanken Liv Försäkring AB 0,23 0,23 2024-12-23
    Gunnar Råbe 0,17 0,17 2024-12-23
    Korosh Fouladi 0,15 0,15 2024-12-23
    Farid Noori 0,15 0,15 2024-12-23
    Maths Wahlström 0,14 0,14 2024-06-26

    Insider trading

    *Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

    Key Numbers

    *Compiled data from Millistream

    Annual reports, prospectus etc.